Published in J Anat on April 09, 2013
Allometry of left ventricular myocardial innervation. J Anat (2013) 0.76
Smaller Absolute Quantities but Greater Relative Densities of Microvessels Are Associated with Cerebellar Degeneration in Lurcher Mice. Front Neuroanat (2016) 0.75
Cardiac Remodeling from Middle Age to Senescence. Front Physiol (2017) 0.75
The efficiency of systematic sampling in stereology and its prediction. J Microsc (1987) 10.24
Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol (2003) 6.99
Stress pathways and heart failure. Cell (1999) 3.80
T-tubule remodeling during transition from hypertrophy to heart failure. Circ Res (2010) 3.57
Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol (2003) 2.57
Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation (2000) 2.44
Differential cardiac remodeling in preload versus afterload. Circulation (2010) 2.20
Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation (1992) 2.16
Retracted Cardiomyogenesis in the aging and failing human heart. Circulation (2012) 2.16
Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload. J Mol Cell Cardiol (1994) 1.77
Spatiotemporal heterogeneity in the induction of ventricular fibrillation by rapid pacing: importance of cardiac restitution properties. Circ Res (1999) 1.67
Cardiac sympathetic rejuvenation: a link between nerve function and cardiac hypertrophy. Circ Res (2007) 1.65
Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy. Am J Pathol (1975) 1.59
The visualisation of cardiovascular innervation in the guinea pig using an antiserum to protein gene product 9.5 (PGP 9.5). J Auton Nerv Syst (1987) 1.44
Estimation of surface area and length with the orientator. J Microsc (1990) 1.38
A review of state-of-the-art stereology for better quantitative 3D morphology in cardiac research. Cardiovasc Pathol (2009) 1.37
Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodents. J Clin Invest (2010) 1.33
Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review. J Am Coll Cardiol (1986) 1.29
Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis (2009) 1.27
Quantitative changes in the capillary bed during developing, peak, and stabilized cardiac hypertrophy in the spontaneously hypertensive rat. Circ Res (1982) 1.26
In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. Am J Physiol (1994) 1.25
Reduced myocardial nerve growth factor expression in human and experimental heart failure. Circ Res (2000) 1.14
Rodent models of heart failure. J Pharmacol Toxicol Methods (2007) 1.10
Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study. Heart (2001) 1.07
Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure. Circulation (1993) 1.05
Morphometry of right ventricular hypertrophy induced by strenuous exercise in rat. Am J Physiol (1982) 1.04
Effect of voluntary exercise on number and volume of cardiomyocytes and their mitochondria in the mouse left ventricle. Basic Res Cardiol (2007) 1.02
Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. Circulation (1998) 1.01
The ultrastructure of the failing heart. Am J Med Sci (1969) 0.92
Stereological characterization of left ventricular cardiomyocytes, capillaries, and innervation in the nondiabetic, obese mouse. Cardiovasc Pathol (2011) 0.92
Myocyte growth in the failing heart. Surg Clin North Am (2004) 0.88
Myocardial remodelling in left ventricular atrophy induced by caloric restriction. J Anat (2011) 0.87
Assessment of left ventricular mass in mice: comparison between two-dimensional and m-mode echocardiography. Echocardiography (2002) 0.86
An unbiased stereological method for efficiently quantifying the innervation of the heart and other organs based on total length estimations. J Appl Physiol (1985) (2010) 0.86
Ultrastructure and histochemistry of rat myocardial capillary endothelial cells in response to diabetes and hypertension. Cell Res (2005) 0.86
Ultrastructure of endothelial cells under flow alteration. Microsc Res Tech (2003) 0.85
Celecoxib modulates hypertrophic signalling and prevents load-induced cardiac dysfunction. Eur J Heart Fail (2008) 0.82
Distribution of mitochondria in normal and hypertrophic myocytes from the rat heart. J Mol Cell Cardiol (1986) 0.79
Quantitative histology of the hypertrophied human heart. Fed Proc (1981) 0.79
Altered microRNA expression in human heart disease. Physiol Genomics (2007) 5.64
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J (2014) 5.21
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1. Nat Med (2011) 3.96
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail (2010) 3.90
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet (2012) 3.66
Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol (2011) 3.13
Moderate hypothermia for severe cardiogenic shock (COOL Shock Study I & II). Resuscitation (2012) 2.70
Calcium cycling in congestive heart failure. J Mol Cell Cardiol (2002) 2.46
Insulin causes [Ca2+]i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium. Circulation (2005) 1.93
Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Proc Natl Acad Sci U S A (2002) 1.88
NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation (2005) 1.87
N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation (2005) 1.86
Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J (2008) 1.83
Influence of pyruvate on contractile performance and Ca(2+) cycling in isolated failing human myocardium. Circulation (2002) 1.73
Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy. Circulation (2009) 1.71
First prospective, multi-centre clinical experience with a novel left ventricular quadripolar lead. Europace (2011) 1.70
Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail (2011) 1.61
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2009) 1.61
Microdialysis-based analysis of interstitial NO in situ: NO synthase-independent NO formation during myocardial ischemia. Cardiovasc Res (2007) 1.58
Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction--results of the Aldo-DHF trial. Int J Cardiol (2013) 1.56
Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion. Am J Obstet Gynecol (2008) 1.51
Increased SR Ca2+ cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats. Cardiovasc Res (2005) 1.51
Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices. J Mol Cell Cardiol (2006) 1.50
Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes. J Mol Cell Cardiol (2008) 1.50
Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction. Eur J Heart Fail (2015) 1.49
Building intelligent environments with Smart-Its. IEEE Comput Graph Appl (2004) 1.44
Inotropic Effects of Experimental Hyperthermia and Hypothermia on Left Ventricular Function in Pigs-Comparison With Dobutamine. Crit Care Med (2016) 1.41
Mild hypothermia attenuates circulatory and pulmonary dysfunction during experimental endotoxemia. Crit Care Med (2013) 1.41
Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2011) 1.40
Coronary microembolization: the role of TNF-alpha in contractile dysfunction. J Mol Cell Cardiol (2002) 1.32
Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice. Am J Pathol (2007) 1.26
Heart failure-associated changes in RNA splicing of sarcomere genes. Circ Cardiovasc Genet (2010) 1.23
Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation. Cardiovasc Res (2010) 1.22
Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure. Cardiovasc Res (2002) 1.21
In situ calibration of nucleoplasmic versus cytoplasmic Ca²+ concentration in adult cardiomyocytes. Biophys J (2011) 1.17
Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study. Eur J Heart Fail (2011) 1.16
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace (2013) 1.16
Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. J Neurosci (2006) 1.15
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res (2012) 1.14
EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Eur J Heart Fail (2014) 1.13
Endothelin-1 enhances nuclear Ca2+ transients in atrial myocytes through Ins(1,4,5)P3-dependent Ca2+ release from perinuclear Ca2+ stores. J Cell Sci (2007) 1.10
Telethonin deficiency is associated with maladaptation to biomechanical stress in the mammalian heart. Circ Res (2011) 1.07
Functional relevance of the stretch-dependent slow force response in failing human myocardium. Circ Res (2004) 1.07
Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: potential for use in myocardial perfusion imaging. J Cardiovasc Pharmacol (2003) 1.07
Benefit of Exercise in Atrial Fibrillation: Diastolic Function Matters! J Am Coll Cardiol (2016) 1.06
Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms. Circulation (2007) 1.06
Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Metabolism (2013) 1.04
Adherence of heart failure patients to exercise: barriers and possible solutions: a position statement of the Study Group on Exercise Training in Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2012) 1.04
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail (2013) 1.04
Galectin-3 in heart failure with preserved ejection fraction. Eur J Heart Fail (2013) 1.03
Effect of voluntary exercise on number and volume of cardiomyocytes and their mitochondria in the mouse left ventricle. Basic Res Cardiol (2007) 1.02
Serum and glucocorticoid inducible kinases in the regulation of the cardiac sodium channel SCN5A. Cardiovasc Res (2003) 1.01
Functional cardiac lipolysis in mice critically depends on comparative gene identification-58. J Biol Chem (2013) 1.00
Cytosolic herpes simplex virus capsids not only require binding inner tegument protein pUL36 but also pUL37 for active transport prior to secondary envelopment. Cell Microbiol (2012) 1.00
Na(+)-Ca(2+) exchanger overexpression predisposes to reactive oxygen species-induced injury. Cardiovasc Res (2003) 0.99
The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction. J Am Heart Assoc (2013) 0.98
Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure. Eur Heart J (2009) 0.98
Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups. Eur J Heart Fail (2013) 0.97
Transcriptional basis for exercise limitation in male eNOS-knockout mice with age: heart failure and the fetal phenotype. Am J Physiol Heart Circ Physiol (2005) 0.97
The slow force response to stretch in atrial and ventricular myocardium from human heart: functional relevance and subcellular mechanisms. Prog Biophys Mol Biol (2008) 0.97
Heart failure with normal left ventricular ejection fraction: what is the evidence? Trends Cardiovasc Med (2008) 0.96
Impaired left atrial function in heart failure with preserved ejection fraction. Eur J Heart Fail (2014) 0.96
The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction. Eur J Heart Fail (2010) 0.95
Overexpression of CaMKIIδc in RyR2R4496C+/- knock-in mice leads to altered intracellular Ca2+ handling and increased mortality. J Am Coll Cardiol (2011) 0.93
Sodium and the heart: a hidden key factor in cardiac regulation. Cardiovasc Res (2003) 0.93
Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy. J Biol Chem (2012) 0.92
Insulin-like growth factor-1 exerts Ca2+-dependent positive inotropic effects in failing human myocardium. Circ Res (2003) 0.92
Impact of diabetes on left ventricular diastolic function in patients with arterial hypertension. Eur J Heart Fail (2007) 0.92
Intracellular dyssynchrony of diastolic cytosolic [Ca²⁺] decay in ventricular cardiomyocytes in cardiac remodeling and human heart failure. Circ Res (2013) 0.92
Spongious hypertrophic cardiomyopathy in patients with mutations in the four-and-a-half LIM domain 1 gene. Circ Cardiovasc Genet (2012) 0.91
Stretch-dependent modulation of [Na+]i, [Ca2+]i, and pHi in rabbit myocardium--a mechanism for the slow force response. Cardiovasc Res (2005) 0.91
Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial. Eur J Heart Fail (2014) 0.90
Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart. Eur J Pharmacol (2010) 0.89
Stretch-dependent slow force response in isolated rabbit myocardium is Na+ dependent. Cardiovasc Res (2003) 0.89
Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction. Eur Heart J (2013) 0.89
A stepwise psychotherapy intervention for reducing risk in coronary artery disease (SPIRR-CAD) - rationale and design of a multicenter, randomized trial in depressed patients with CAD. J Psychosom Res (2011) 0.88
The seasonal peculiarities of force-frequency relationships in active ground squirrel Spermophilus undulatus ventricle. Cryobiology (2007) 0.88
A network against failing hearts--introducing the German "Competence Network Heart Failure". Int J Cardiol (2009) 0.88
Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction. Eur Heart J (2011) 0.88
Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction. Eur J Heart Fail (2014) 0.87
Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction. Clin Res Cardiol (2010) 0.87
Cancer induces cardiomyocyte remodeling and hypoinnervation in the left ventricle of the mouse heart. PLoS One (2011) 0.87
Impact of obstructive sleep apnoea on diastolic function. Eur Respir J (2012) 0.86